• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Multiple myeloma: biology and therapy.

作者信息

Barlogie B, Epstein J

机构信息

University of Texas System M. D. Anderson Cancer Center, Department of Hematology, Houston.

出版信息

J Cancer Res Clin Oncol. 1990;116(1):109-11. doi: 10.1007/BF01612651.

DOI:10.1007/BF01612651
PMID:2312600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12200314/
Abstract
摘要

相似文献

1
Multiple myeloma: biology and therapy.多发性骨髓瘤：生物学与治疗
J Cancer Res Clin Oncol. 1990;116(1):109-11. doi: 10.1007/BF01612651.
2
[Improved prognosis of generalized AL-amyloidosis in a patient with multiple myeloma treated according to the VAD protocol].[采用VAD方案治疗的多发性骨髓瘤患者合并全身性AL淀粉样变性的预后改善]
Ter Arkh. 2003;75(8):81-2.
3
Is there still place for VAD as primary treatment for patients with multiple myeloma who are candidates for high-dose therapy?
Leuk Lymphoma. 2006 Nov;47(11):2271-2. doi: 10.1080/10428190600908620.
4
[Could the VAD protocol be the first line therapy for multiple myeloma in subSaharan Africa? The Brazzaville experience].
Sante. 2011 Jul-Sep;21(3):169-70.
5
Assessment of early paraprotein response to vincristine-doxorubicin-dexamethasone chemotherapy may help guide therapy in multiple myeloma.
Intern Med J. 2004 Sep-Oct;34(9-10):576-8. doi: 10.1111/j.1445-5994.2004.00689.x.
6
The treatment of multiple myeloma.多发性骨髓瘤的治疗
N Engl J Med. 1994 Feb 17;330(7):484-9. doi: 10.1056/NEJM199402173300709.
7
Initial cytoreductive treatment with thalidomide plus bolus vincristine/doxorubicin and reduced dexamethasone followed by autologous stem cell transplantation for multiple myeloma.沙利度胺联合长春新碱/多柔比星和地塞米松减量方案诱导缓解后自体造血干细胞移植治疗多发性骨髓瘤。
Invest New Drugs. 2011 Feb;29(1):175-81. doi: 10.1007/s10637-009-9343-4. Epub 2009 Oct 13.
8
Phase II trial of rhIL-6 (interleukin-6) prior to and concurrently with VAD (vincristine, doxorubicin and dexamethasone) chemotherapy for patients with multiple myeloma.重组人白细胞介素-6（rhIL-6）在多发性骨髓瘤患者接受VAD（长春新碱、阿霉素和地塞米松）化疗之前及化疗期间进行的II期试验。
Eur J Cancer. 1997 Feb;33(2):307-11. doi: 10.1016/s0959-8049(96)00383-8.
9
Amyloid deposition of systemic myeloma-associated amyloidosis excludes actinic elastotic material.系统性骨髓瘤相关淀粉样变性的淀粉样沉积不包括光化性弹性组织变性物质。
Eur J Dermatol. 2002 Nov-Dec;12(6):607-8.
10
VAD followed by VMCP: an alternative regimen for multiple myeloma.
Med Oncol. 2002;19(2):105-8. doi: 10.1385/MO:19:2:105.

引用本文的文献

1
Serum 8-isoprostane levels and paraoxonase 1 activity in patients with stage I multiple myeloma.I期多发性骨髓瘤患者的血清8-异前列腺素水平和对氧磷酶1活性
Redox Rep. 2016 Sep;21(5):204-8. doi: 10.1179/1351000215Y.0000000034. Epub 2016 Feb 26.

本文引用的文献

1
Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. IV. L-Phenylalanine mustard (NSC-8806).新型化疗药物治疗多发性骨髓瘤的评估。IV. L-苯丙氨酸氮芥（NSC-8806）。
Cancer Chemother Rep. 1962 Aug;21:87-99.
2
Effective treatment of advanced multiple myeloma refractory to alkylating agents.对烷化剂难治的晚期多发性骨髓瘤的有效治疗。
N Engl J Med. 1984 May 24;310(21):1353-6. doi: 10.1056/NEJM198405243102104.
3
Treatment of multiple myeloma with recombinant alpha-interferon.用重组α干扰素治疗多发性骨髓瘤。
Blood. 1986 Feb;67(2):275-8.
4
High-dose glucocorticoid treatment of resistant myeloma.大剂量糖皮质激素治疗难治性骨髓瘤。
Ann Intern Med. 1986 Jul;105(1):8-11. doi: 10.7326/0003-4819-105-1-8.
5
Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells.培养的人骨髓瘤细胞产生骨吸收细胞因子淋巴毒素。
N Engl J Med. 1987 Aug 27;317(9):526-32. doi: 10.1056/NEJM198708273170902.
6
Recombinant interferon alfa-2b (Intron A) as post-induction therapy for responding multiple myeloma patients. M84 protocol.重组干扰素α-2b（英特龙A）作为反应性多发性骨髓瘤患者诱导治疗后的疗法。M84方案。
Cancer Treat Rev. 1988 Jan;15 Suppl A:43-8. doi: 10.1016/0305-7372(88)90073-4.
7
Alteration and abnormal expression of the c-myc oncogene in human multiple myeloma.人多发性骨髓瘤中c-myc癌基因的改变与异常表达。
Blood. 1988 Jan;71(1):30-5.
8
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas.人多发性骨髓瘤中自分泌产生及对BSF-2/IL-6的需求
Nature. 1988 Mar 3;332(6159):83-5. doi: 10.1038/332083a0.
9
Identification of a second transforming gene, rasn, in a human multiple myeloma line with a rearranged c-myc allele.
Blood. 1988 Oct;72(4):1163-7.
10
Correlated flow cytometric analysis of H-ras p21 and nuclear DNA in multiple myeloma.
Blood. 1988 Aug;72(2):796-800.